Bosco Samuel MD is categorized under Business Services (Unclassified) in Albany, NY and active since 2013.
Bosco Samuel MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Samuel Bosco at the company’s single location by writing to 315 South Manning Boulevard, Albany, New York NY 12208 or by phoning (518) 454-1371. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bosco Samuel MD |
| Contact Person: | Samuel Bosco |
| Address: | 315 South Manning Boulevard, Albany, New York 12208 |
| Phone Number: | (518) 454-1371 |
| Website Address: | sphcs.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Bosco Samuel MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Samuel Bosco for inquiries that concern Bosco Samuel MD by calling the company number (518) 454-1371, as your correspondence is most welcome. Additionally, the physical location of the single location of Bosco Samuel MD can be found at the coordinates 42.657412,-73.803999 as well as the street address 315 South Manning Boulevard in Albany, New York 12208.
For its online presence, you may visit Bosco Samuel MD’s website at sphcs.org and engage with its social media outlets through on Twitter and on Facebook.